Glanbia PLC (GL9) - Total Liabilities

Latest as of December 2025: €2.05 Billion EUR ≈ $2.39 Billion USD

Based on the latest financial reports, Glanbia PLC (GL9) has total liabilities worth €2.05 Billion EUR (≈ $2.39 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore GL9 net assets growth trend to track the company's year-over-year net asset growth rate.

Glanbia PLC - Total Liabilities Trend (1985–2025)

This chart illustrates how Glanbia PLC's total liabilities have evolved over time, based on quarterly financial data. See Glanbia PLC (GL9) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Glanbia PLC Competitors by Total Liabilities

The table below lists competitors of Glanbia PLC ranked by their total liabilities.

Company Country Total Liabilities
Suzhou Everbright Photonics Co. Ltd. A
SHG:688048
China CN¥320.36 Million
Churchill Downs Incorporated
NASDAQ:CHDN
USA $6.43 Billion
Compagnie du Cambodge
PA:CBDG
France €104.90 Million
Cogent Biosciences Inc
NASDAQ:COGT
USA $301.24 Million
Inner Mongolia Junzheng Energy & Chemical Group Co Ltd
SHG:601216
China CN¥12.18 Billion
Capital Securities Corp. Ltd.
SHG:601136
China CN¥40.50 Billion
Ameris Bancorp
NYSE:ABCB
USA $24.03 Billion
QMMM Holdings Limited Ordinary Shares
NASDAQ:QMMM
USA $71.22K

Liability Composition Analysis (1985–2025)

This chart breaks down Glanbia PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see GL9 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.36 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.06 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.52 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Glanbia PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Glanbia PLC (1985–2025)

The table below shows the annual total liabilities of Glanbia PLC from 1985 to 2025.

Year Total Liabilities Change
2025-12-31 €2.05 Billion
≈ $2.39 Billion
+13.60%
2024-12-31 €1.80 Billion
≈ $2.11 Billion
+8.11%
2023-12-31 €1.67 Billion
≈ $1.95 Billion
-16.33%
2022-12-31 €1.99 Billion
≈ $2.33 Billion
+5.53%
2021-12-31 €1.89 Billion
≈ $2.21 Billion
+29.84%
2020-12-31 €1.45 Billion
≈ $1.70 Billion
-14.44%
2019-12-31 €1.70 Billion
≈ $1.99 Billion
+12.55%
2018-12-31 €1.51 Billion
≈ $1.76 Billion
+37.07%
2017-12-31 €1.10 Billion
≈ $1.29 Billion
-25.67%
2016-12-31 €1.48 Billion
≈ $1.73 Billion
-6.69%
2015-12-31 €1.59 Billion
≈ $1.86 Billion
+22.02%
2014-12-31 €1.30 Billion
≈ $1.52 Billion
+24.01%
2013-12-31 €1.05 Billion
≈ $1.23 Billion
-15.41%
2012-12-31 €1.24 Billion
≈ $1.45 Billion
-6.39%
2011-12-31 €1.33 Billion
≈ $1.55 Billion
+10.21%
2010-12-31 €1.20 Billion
≈ $1.41 Billion
+6.59%
2009-12-31 €1.13 Billion
≈ $1.32 Billion
-8.07%
2008-12-31 €1.23 Billion
≈ $1.43 Billion
+30.30%
2007-12-31 €941.72 Million
≈ $1.10 Billion
-2.14%
2006-12-31 €962.29 Million
≈ $1.13 Billion
+14.13%
2005-12-31 €843.14 Million
≈ $985.72 Million
+36.38%
2004-12-31 €618.24 Million
≈ $722.79 Million
+6.54%
2003-12-31 €580.30 Million
≈ $678.43 Million
-8.63%
2002-12-31 €635.08 Million
≈ $742.47 Million
-23.33%
2001-12-31 €828.33 Million
≈ $968.41 Million
-6.93%
2000-12-31 €890.02 Million
≈ $1.04 Billion
-9.37%
1999-12-31 €982.05 Million
≈ $1.15 Billion
-10.61%
1998-12-31 €1.10 Billion
≈ $1.28 Billion
-5.25%
1997-12-31 €1.16 Billion
≈ $1.36 Billion
+221.17%
1996-12-31 €361.02 Million
≈ $422.07 Million
-21.32%
1995-12-31 €458.87 Million
≈ $536.47 Million
+0.72%
1994-12-31 €455.58 Million
≈ $532.62 Million
+25.09%
1993-12-31 €364.19 Million
≈ $425.78 Million
+27.82%
1992-12-31 €284.93 Million
≈ $333.11 Million
+37.30%
1991-12-31 €207.52 Million
≈ $242.61 Million
+8.65%
1990-12-31 €191.00 Million
≈ $223.30 Million
+58.87%
1989-12-31 €120.22 Million
≈ $140.55 Million
+72.55%
1988-12-31 €69.67 Million
≈ $81.46 Million
+24.67%
1987-12-31 €55.89 Million
≈ $65.34 Million
-10.72%
1986-12-31 €62.60 Million
≈ $73.18 Million
+6.85%
1985-12-31 €58.59 Million
≈ $68.49 Million
--

About Glanbia PLC

IR:GL9 Ireland Packaged Foods
Market Cap
$6.49 Billion
€5.55 Billion EUR
Market Cap Rank
#3198 Global
#6 in Ireland
Share Price
€22.98
Change (1 day)
+0.35%
52-Week Range
€12.10 - €24.84
All Time High
€24.84
About

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes produ… Read more